- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 14.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 11.01M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.15M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $289.49K |
| Capex | Q1 2026 · Mar 31, 2025 | $178.45K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$8.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.51M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $39.25M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $33.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $5.13M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $990.02K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $50.57M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $38.75M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $22.14M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$1.05M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.14M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.8M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.39M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.3M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $49.93M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $39.22M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $60.96M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $50.05M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.59 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.40 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.59 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.40 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.14M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.89M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.11M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.49M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$3.91M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.94M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.22M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $57.35K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $11.81K |
| Revenue | Q1 2026 · Mar 31, 2026 | $104.57K |
| Revenue | Q1 2026 · Mar 31, 2025 | $47.15K |